In a study of over 11,500 patients who had BI-RADS 4 breast lesions with no prior history of breast cancer, researchers found no statistically significant differences between digital mammography and digital breast tomosynthesis in cancer detection rates or biopsy-derived positive predictive value.

A new study revealed that an emerging artificial intelligence (AI)-enabled software tool led to improved sensitivity, specificity and inter-observer agreement for the diagnosis of indeterminate pulmonary nodules on chest computed tomography (CT) scans.

A closer look at the literature suggests the combination of digital breast tomosynthesis (DBT) and two-dimensional (2D) digital mammography (DM) has relatively equivalent cancer detection rates as using DM alone, according to a recent presentation at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) conference.

Amid a glut of unnecessary imaging requests, common worklist frustrations and perceptions from other clinicians that they can interpret medical images just as well, recognizing your role as a humble difference maker may provide the ultimate RVU for patients.

Catch up on the top radiology content of the past week.

While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.

In a recent video interview, two radiology professors from the Yale School of Medicine discussed the impact of the iodinated contrast media (ICM) shortage and potential strategies, ranging from ICM dose reduction to possible deferment of non-urgent imaging, that may provide a viable path moving forward.

Researchers found that Korean women with a combination of benign breast disease and BI-RADS category C or BI-RADS category D breast density had a nearly threefold or greater 10-year risk for breast cancer.

In a recent lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) conference, Linda Moy, MD, reviewed key tips for optimizing magnetic resonance imaging (MRI) of the breast.

Could the emerging artificial intelligence platforms Saige-Dx and Quantib Prostate 2.0 improve cancer detection with mammography and prostate MRI?

Is it a thoughtless verbal reflex or a failure to go beyond a surface read of imaging?

The company will spotlight the breast cancer risk stratification software Volpara Risk Pathways and a new mammography training collaboration with Mammography Educators.

Catch up on the top radiology content of the past week.

In recent video interviews, Syam Reddy, MD, Judy Yee, MD and Anand Narayan, MD, discussed various benefits of computed tomography colonography (CTC) for colorectal cancer screening, the underutilization of the CTC procedure and steps moving forward to improve access to this procedure.

In addition to addressing workplace stressors, leaders in radiology should have an increased awareness of other key drivers of burnout, including inclusivity issues and challenges for radiologists who are managing their own health conditions.

Given the challenges with the shortage of the iodinated contrast agent Omnipaque, national and state organizations have issued suggested risk mitigation and conservation strategies to reprioritize imaging needs during this temporary shortage.

What is the diagnosis?

Could low-dose X-ray technology reinvent imaging exams for children?

While some have raised questions and concerns about a possible loss of autonomy with the increasing presence of private equity in radiology, this author says potential benefits of such an alliance, including access to new technologies, career development and a strong patient focus, go beyond the expected economies of scale.

Sharing insights from their recent presentation at the American Roentgen Ray Society (ARRS) conference in a new video interview, researchers discussed how sex-based differences have an impact in the imaging and diagnosis of ischemic heart disease (IHD) in women.